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Abstract
Women oxidize more fat as compared to men during endurance exercise and several groups have shown that the mRNA
content of selected genes related to fat oxidation are higher in women (e.g. hormone sensitive lipase, b-hydroxyacyl-CoA
dehydrogenase, CD36). One of the possible mechanisms is that women tend to have a higher area percentage of type I
skeletal muscle fibers as compared with men. Consequently, we hypothesized that sex would influence the basal mRNA and
protein content for genes involved in metabolism and the determination of muscle fiber type. Muscle biopsies from the
vastus lateralis were collected from healthy men and women. We examined mRNA content globally using Affymetrix
GeneChips, and selected genes were examined and/or confirmed by RT-PCR. Furthermore, we examined protein content by
Western blot analysis. Stringent gene array analysis revealed 66 differentially expressed genes representing metabolism,
mitochondrial function, transport, protein biosynthesis, cell proliferation, signal transduction pathways, transcription and
translation. Stringent gene array analysis and RT-PCR confirmed that mRNA for; acyl-coenzyme A acyltransferase 2 (ACAA2),
trifunctional protein b (HADHB), catalase, lipoprotein lipase (LPL), and uncoupling protein-2 (UCP-2) were higher in women.
Targeted gene analysis revealed that myosin heavy chain I (MHCI), peroxisome proliferator-activated receptor (PPAR)d were
higher in women compared with men. Surprisingly, there were no significant sex based differences in protein content for
HADHB, ACAA2, catalase, PPARd, and MHC1. In conclusion, the differences in the basal mRNA content in resting skeletal
muscle suggest that men and women are transcriptionally ‘‘primed’’ for known physiological differences in metabolism
however the mechanism behind sex differences in fiber type remains to be determined.
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Introduction
Skeletal muscle is the most abundant tissue in the human body
[1], and there are major differences between women and men in
energy metabolism, fiber type composition, and contractile speed
[2,3,4]; however, the mechanisms behind these differences are
unknown. A number of groups have reported differences in
exercise related substrate metabolism between men and women,
specifically that women oxidize more lipid and less carbohydrate
than men [5,6,7,8,9,10,11]. Similar studies in rats have also found
gender differences in lipid metabolism, specifically that female rats
have greater lipid oxidation and muscle lipoprotein lipase (LPL)
activity, as compared with male rats [12,13]. Furthermore, when
female rats are oophorectomized, lipid oxidation is lower during
endurance exercise [14]. The exact mechanisms behind such
observations are unclear; however, sex differences in mRNA
content and protein expression appear to be directionally
consistent with the observed metabolic differences present during
exercise. Specifically, women compared to age and fitness matched
men have higher mRNA content for LPL [15], membrane fatty
acid transport protein 1 (FATm) [16], FAT/CD36 transporter and
plasma membrane fatty acid binding protein (FABPpm) [15],
citrate synthase [17], b-hydroxyacyl-CoA dehydrogenase (b-HAD)
[17], and hormone sensitive lipase [11]. On the whole body level,
women show greater lipolysis [5,18], and greater uptake of plasma
free fatty acids [18], and use more intramuscular triacylglycerol
[11,19,20] than men.
Futhermore, a sex difference in muscle fiber composition has
been found in different skeletal muscles, such as, erector spinae [21],
internal and external intercostal, latissimus dorsi [22], biceps brachii [23],
vastus medialis [24], and vastus lateralis [5,25,26,27,28,29,30].
Although studies concerning sex differences in skeletal muscle
fiber type have shown inconsistent results [4,25,26,28,29,31,32],
women generally have a greater relative type I fiber area
[4,5,26,27,30], a smaller relative area of type II fibers and a
greater percentage area of type I fibers [4,5,26,27,28,32]. The
potential molecular mechanisms behind these sex differences have
not been evaluated for the mRNA species of the genes involved in
muscle development, or fiber-type determination and differentia-
tion.
The molecular mechanisms for the observed differences in
substrate oxidation and fiber type between men and women are
PLoS ONE | www.plosone.org 1 July 2009 | Volume 4 | Issue 7 | e6335unknown. In this study we used a targeted approach (RT-PCR) to
evaluate mRNA species of the genes involved in muscle
development, fiber-type determination and differentiation, and a
microarray comparison to evaluate the many more potential
mRNA species that are required for lipid metabolism and fiber
type in human skeletal muscle, which may yield important data for
understanding potential novel mechanisms. Gene array technol-
ogy has provided a rapid and efficient way to screen a large
number of mRNAs in order to identify potential targets and
pathways for further research. Recently, several groups have used
gene arrays to identify novel transcriptional programs related to
human muscle repair, inflammation, protein synthesis and cellular
control in skeletal muscle after various interventions such as
exercise [33,34,35], immobilization [36], and drug treatments
[37]. A few groups have done targeted gene expression profiles to
examine sex differences in humans [38,39] and mice [40]. In this
study, skeletal muscle biopsies from healthy, young men and
women were analyzed for mRNA abundance of over 23,000 genes
by Affymetrix gene array analysis with an a priori hypothesis that
mRNA species involved in lipid oxidation, muscle development,
and fiber-type determination and differentiation would be
different in women compared with men. Furthermore, we
hypothesized that this global analysis would identify novel mRNA
targets that are relevant to biological pathways that differ in
skeletal muscle between men and women.
Materials and Methods
Participants
These studies were approved by the Human Research Ethics
Board of McMaster University. The present study used muscle
samples from two different studies that recruited subjects using
identical criteria and subject characteristics were not significantly
different (Table 1). All subjects were between the ages of 18 and 35,
healthy, recreationally active, and non-smokers. Highly trained
athleteswere excluded from the studies.Allfemaleparticipantswere
eumenorrheic. The present study only compared muscle samples
collected at baseline (before manipulation) thus termed ‘‘resting
muscle’’ from the two studies. In study 1, 14 women and 13 men
volunteered to participate butwe onlyused samples from12 women
and 12 men. Subject characteristics have been previously published
[30] but can be viewed in Table 1. In study 2, 24 healthy,
recreationally active men (n=11) and women (n=13) participated
[41]. Data from these subjects regarding diet, CHO, protein and fat
oxidation has been previously reported [41], and demonstrated that
women had higher fat oxidation and lower protein and carbohy-
drate oxidation during endurance exercise as compared with men.
The muscle samples collected pre-exercise were used for the present
study and only samples from women in the follicular phase of their
menstrual cycle were used as there was little difference in mRNA
content of metabolic related genes between follicular and luteal
phase women (Figure S1)compared to differencesdueto sex(Figure
S2) (unpublished data). Study 1 samples were used to acquire the
gene array data, histochemical data is a combination of a
representative subset of subjects from both studies, and RNA and
protein data was acquired from study 2 samples. A comparison of
subject characteristics is reported in Table 1. All study participants
gave written consent to participate in the study.
Acquisition of muscle samples
Muscle samples were obtained from the vastus lateralis muscle,
,15 cm proximal to the lateral knee joint line, using a custom
suction-modified Bergstrom needle. Biopsies were taken at rest and
all subjects refrained from any exercise for at least 3 days before
the muscle biopsy. All biopsies were completed in the morning.
Approximately 60 mg of muscle tissue was divided and snap-
frozen in liquid nitrogen and stored in a 280uC freezer for RNA
and protein analysis.
Histochemical analysis
Histochemical analyses were conducted on samples from study
1and 2, asdescribed byYasudaetal. [30].Briefly,the OCTmounted
muscle samples were serially sectioned to 10 mm thickness, and
slides were preincubated at a pH value of 4.60 in 50 mM potassium
acetate, 17.5 mM calcium chloride for 7 min. Slides were rinsed
with distilled, deionized water (ddH20) between each of the
following steps. Slides were incubated in 3 mM ATP using an
alkaline solution (75 mM glycine, 40.5 mM calcium chloride,
75 mM NaCl, 67.5 mM NaOH, pH 9.4) for 45 min at 37uC with
agitation at regular intervals. They were incubated consecutively in
Table 1. Subject characteristics from study #1 and study #2.
Study #1 Study #2
Men (n=12) Women (n=12) Men (n=11) Women (n=13)
Age (yr) 21612 2 612 1 612 2 62
Weight (kg) 79646 1 62* 80636 3 62*
Height (cm) 179621 6 4 61* 178611 6 5 61*
BF (%) 18612 5 61* 19652 9 65*
FFM (kg) 64634 4 61* 59615 2 61*
BMI 25612 3 612 5 612 3 61
VO2peak (ml*kg body wt-1*min-1) NA NA 45613 9 62*
(ml*kg FFM-1*min-1) NA NA 56615 4 63
Menstral cycle 7=Fol, 5=Lut Fol
Oral Contraceptive use 6=OC, 6=NOC 6=OC, 7=NOC
Feeding state BoostH 2 hrs before biopsy Fasted (10–12 hrs)
*significant difference between men and women for each study (P,0.05). There is no significant difference between the men or the women in study 1 compared with
study 2. BF; body fat, BMI; body mass index, Fol; follicular phase, Lut; luteal phase, OC; oral contraceptives.
doi:10.1371/journal.pone.0006335.t001
Sex Difference in mRNA Content
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ammonium sulphide for 30 s at room temperature. Sections were
photographed at 2006magnifications with a microscope (Olympus
America Inc., Melville, NY) in conjunction with a SPOT digital
camera (Model: SP401-115, SPOT Diagnostic Instruments Inc.,
MI). Based on the staining intensity at pH 4.60, the three fiber types
were classified as Type I (dark), IIa (light) and IIx (intermediate).
Cross-sectional areas of the muscle fibers (mm
2) were determined
using an image analysis program (Image Pro, V6.0, Media
Cybernetics Inc., Silver Spring, MD).
Microarray Preparation
Muscle samples from study 1 were used to extract RNA, and the
RNA was prepared according to Affymetrix recommendations
(Santa Clara, CA). In brief, muscle samples were homogenized in
TRIzol Reagent (Life Technologies, Rockville, MD) by shaking in
a mixer mill with tungsten carbide beads as recommended by the
manufacturer (Qiagen, Life Technologies, Rockville, MD). RNA
was purified using an RNeasy Mini Kit (Qiagen, Chatsworth, CA).
Ten micrograms of purified RNA was reverse transcribed using
SuperScript II Reverse Transcriptase and T7-(dT)24 primer
followed by second strand DNA synthesis as per the manufactur-
er’s instructions (Life Technologies, Rockville, MD). Contami-
nants were removed from the samples by phenol-chloroform-
isoamyl alcohol extraction, and the clean cDNA was recovered by
ethanol precipitation, using a RNA Transcript Labeling Kit (Enzo
Diagnostics, Farmingdale, NY), it was further converted into
biotin-labeled cRNA, as per manufacturer’s instructions. More-
over, cRNA was purified using a RNeasy Mini Kit (Quiagen, Life
Technologies, Rockville, MD) and fragmented in pieces ,200
bases by incubation in fragmentation buffer. Samples were stored
at 220uC until hybridization.
Samples were hybridized on human HG-U133 Plus 2.0 Arrays
using protocols as recommended by Affymetrix (Affymetrix, Santa
Clara, CA). In brief, 24 gene chips were used to compare 12
women to 12 men. Biotinylated cRNA was hybridized for 16 h at
45uC in a GeneChip Hybridization Oven 640. Arrays were placed
in a GeneChip Fluidic Station 400 for a series of washes, followed
by incubation with streptavidin-conjugated phycoerythrin. Finally,
arrays were scanned with a GeneArray Scanner (Agilent, Palo
Alta, CA) and analyzed using GeneChip Analysis software
(Affymetrix, Santa Clara, CA).
Statistical Analysis of MicroArray
The statistical analysis was based on the Affymetrix signal (MAS
5.0 algorithm). Exploratory statistical tools were used to check data
quality. There were no quality control problems with the data. The
data was then filtered based on the given algorithms for gene
content levels, which filtered out genes that have low content levels
compared to background (Affymetrix Absent Calls). When a
minimum of 19 out of 24 gene replicates read as Affymetrix Absent
Calls, the gene is filtered out. An ANOVA model withlog (base 2) of
the Affymetrix signal as a response is fitted for each one of the genes
that are not filtered based on Affymetrix Absent Calls. Significant
differential content is calculated by the NLOGP (2log10(P-value)).
A gene was considered to be differentially expressed if the NLOGP
measure wasgreaterthan the 4,and the foldchange wasat least 1.2.
TableS1.ProctorandGambleusethesecriteriafortheirAffymetrix
gene array analyses [42]. The negative log of the p value (NLOGP)
was calculated from (2log10 (NLOGP 4=p value threshold of
0.0001), where the p value is a summary measure of the statistical
significance for the corresponding comparison.
Gene annotation and functional analysis
Gene function and characterization information was obtained
from the Affymetrix website: http://www.affymetrix.com/analysis/
index.affx. Further description was obtained from various databases
at the National Center for Biotechnology Information. iPath
TM
(Invitrogen) was used to compared differentially regulated genes
against 225 signaling and metabolic human biological pathway maps
created for Invitrogen
TM by GeneGo. (http://escience.invitrogen.
com/ipath). Differentially regulated gene were also run against a
Connectivity Map, which is a gene expression databasewith statistical
scoring algorithm to link drug treatment, genes, and diseases.
All gene array data can be accessed via Gene Expression
Omnibus (GEO) http://www.ncbi.nlm.nih.gov/geo/. Accession
#GSE14901. The data used for this study were the PRECAST
values (Table S1) only from a larger study ‘‘Limb immobilization
induces a coordinate down-regulation of mitochondrial and other
metabolic pathways in men and women’’.
Table 2. Primer Sequences.
Gene Name Forward Primer Reverse Primer
beta2-microglobulin ggctatccagcgtactccaa gatgaaacccagacacatagca
Catalase actgaggtccaccctgactac tcgcattcttaggcttctca
Lipoprotein Lipase (LPL) gaaaggcacctgcggtatt catgccgttctttgttctgta
Uncoupling protein-2 (UCP-2) tcatcacctttcctctggatac agaatggtgcccatcacac
Acyl-coenzyme A acyltransferase-2 (ACAT2) ggcaggagaagcaagatga gcaccattgaaggaacctatg
Aldehyde dehydrogenase 1 family member A1 (ALDH1A1) cgccagacttacctgtcctact ctcctcagttgcaggattaaag
Trifunctional protein b subunit (HADHB) aaacaagcaatgtggctagaga ggcttggttggcagagatac
Myosin Heavy Chain I (MHCI) cctggaacatctggagacct agctgctttcggaccttct
Myosin Heavy Chain IIa (MHCIIa) caatctagctaaattccgcaagc tcacttatgacttttgtgtgtgaacct
Myosin Heavy Chain IIx (MHCIIx) aaatggtggaaagaagagagtcc aatacagcttcatccagggc
PGC-1alpha ttgctaaacgactccgagaa tgcaaagttccctctctgct
PPARdelta actgagttcgccaagagcat gtgcacgccatacttgagaa
Myostatin gacccgtcgagactcctaca aataccagtgcctgggttca
*All primer sequences are shown 59 to 39, left to right.
doi:10.1371/journal.pone.0006335.t002
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Gene Name Symbol Fold Change NLOGP Biological Process
Metabolism
hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-
Coenzyme A thiolase/enoyl-Coenzyme A hydratase
(trifunctional protein), beta subunit
HADHB 1.32 4.00 lipid metabolism, fatty acid metabolism, fatty acid beta-
oxidation
acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-
oxoacyl-Coenzyme A thiolase)
ACAA2 1.61 5.20 lipid metabolism, fatty acid metabolism, cholesterol
biosynthesis
lipoprotein lipase LPL 1.85 4.30 fatty acid metabolism, circulation, lipid catabolism
aldehyde dehydrogenase 2 family (mitochondrial) ALDH2 1.46 4.70 carbohydrate metabolism, alcohol metabolism
argininosuccinate synthetase 1 ASS1 2.19 6.60 urea cycle, arginine biosynthesis, amino acid biosynthesis
aldehyde dehydrogenase 1 family, member A1 ALDH1A1 21.88 6.00 aldehyde metabolism
Mitochondrial function/oxidative stress
catalase CAT 1.7 6.60 electron transport, response to oxidative stress, hydrogen
peroxide catabolism
uncoupling protein 2 (mitochondrial, proton carrier) UCP2 1.5 4.20 proton transport in the mitochondria
ATP synthase mitochondrial F1 complex assembly factor 1 ATPAF1 21.49 4.00 protein complex assembly
Transport
solute carrier family 25, member 34 SLC25A34 2.37 4.20 transport (mitochondrial carrier)
solute carrier family 1 (glutamate/neutral amino acid
transporter), member 4
SLC1A4 22.2 4.80 dicarboxylic acid transport, neutral amino acid transport
Signal transduction
Rap guanine nucleotide exchange factor (GEF) 2 RAPGEF2 1.21 4.00 intracellular signal transduction, MAPK cascade, cAMP-
mediated signaling ,
transducin-like enhancer of split 1 (E(sp1) homolog,
Drosophila)
TLE1 1.7 4.00 regulation of transcription, signal transduction, frizzled
signaling pathway
kalirin, RhoGEF kinase KALRN 1.31 4.00 protein amino acid phosphorylation, signal transduction,
vesicle-mediated transport
amyloid beta (A4) precursor-like protein 2 APLP2 1.32 5.60 G-protein coupled receptor protein signaling pathway
growth factor receptor-bound protein 10 GRB10 2.41 7.80 intracellular signaling cascade , cell-cell signaling , insulin
receptor signaling pathway
Cyclin-dependent kinase inhibitor 1C (p57, Kip2) CDKN1C 1.71 5.20 regulation of cyclin-dependent protein kinase activity , G1
phase of mitotic cell cycle
family with sequence similarity 13, member A1 FAM13A1 1.32 4.20 signal transduction
mitogen-activated protein kinase 6 MAPK6 21.34 4.00 protein amino acid phosphorylation , cell cycle , signal
transduction
WW domain containing E3 ubiquitin protein ligase 1 WWP1 21.52 7.40 signal transduction, negative regulation of transcription ,
protein ubiquitination, protein modification , ubiquitin
cycle
Rho guanine nucleotide exchange factor (GEF) 10-like ARHGEF10L 21.31 4.10 regulation of Rho protein signal transduction
Transcription
Sine oculis homeobox homolog 1 (Drosophila) SIX1 1.34 4.00 regulation of transcription, muscle development
small nuclear ribonucleoprotein polypeptide N, SNRPN
upstream reading frame
SNRPN, SNURF 21.6 5.90 mRNA metabolism
nuclear receptor interacting protein 1 NRIP1 21.59 4.60 negative and positive regulation of transcription from RNA
polymerase II promoter , androgen receptor signaling
pathway
TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 TBC1D1 21.45 4.40 DNA metabolism , chromosome organization and
biogenesis
cyclin H CCNH 21.21 4.80 regulation of cyclin-dependent protein kinase activity ,
DNA repair , regulation of transcription
LAG1 longevity assurance homolog 6 (S. cerevisiae) LASS6 21.82 4.10 regulation of transcription, lipid biosynthesis
iroquois homeobox protein 3 IRX3 210.92 11.40 regulation of transcription
zinc finger protein 33A ZNF33A 21.57 4.00 regulation of transcription
Protein Biosynthesis and Translation
eukaryotic translation initiation factor 1A, X-linked EIF1AX 1.38 7.30 protein biosynthesis, translational initiation
eukaryotic translation initiation factor 2, subunit 3 gamma,
52 kDa
EIF2S3 1.45 7.20 protein biosynthesis
Sex Difference in mRNA Content
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Muscle biopsy samples from study 2 were used to isolated RNA
as described previously[43]. Briefly, frozen muscle was thawed in a
Tenbroeck homogenizer with 1 ml of TRIzol reagent (Invitrogen,
Carlsbad, CA) and homogenized on ice. The homogenate was
extracted with 200 ml of chloroform. The aqueous phase was
removed and the RNA was precipitated at room temperature
using 500 ml of iso-propanol and washed twice with 75% ethanol.
The final RNA pellet was air dried at room temperature and
resuspended in 14 ml ddH2O and treated with DNaseI. The RNA
samples were quantified by spectrophotometer (A260/A280 $1.5)
and the quality was assessed by agarose gel electrophoresis.
TaqManH Real-time RT-PCR
TaqManH real-time RT-PCR was conducted on total RNA.
Duplex RT-PCR was performed using an iCycler real-time PCR
Gene Name Symbol Fold Change NLOGP Biological Process
FK506 binding protein 9, 63 kDa FKBP9 1.32 4.00 protein folding
similar to Caspase-4 precursor (CASP-4) (ICH-2 protease) (TX
protease) (ICE(rel)-II)
LOC648470 1.9 4.50 proteolysis
JTV1 gene JTV1 21.42 5.80 protein biosynthesis
ubiquitin specific peptidase 31 USP31 21.42 4.10 ubiquitin-dependent protein catabolism
ring finger and CHY zinc finger domain containing 1 RCHY1 21.31 5.10 ubiquitin cycle
ADP-ribosylhydrolase like 1 ADPRHL1 21.61 4.70 protein amino acid ADP-ribosylation
Cell Proliferation
zinc finger protein 36, C3H type-like 2 ZFP36L2 1.48 4.80 cell proliferation
monocyte to macrophage differentiation-associated MMD 1.67 4.10 cytolysis
angiopoietin 1 ANGPT1 1.74 4.30 angiogenesis, signal transduction, cell differentiation,
development
plexin C1 PLXNC1 1.94 4.70 cell adhesion, development
cell division cycle associated 7-like CDCA7L, RAM2 2.45 4.40 positive regulation of cell proliferation
tumor protein D52 TPD52 21.72 5.70 morphogenesis, B cell differentiation, secretion
Down syndrome critical region gene 1-like 1 DSCR1L1 21.67 5.90 central nervous system development, calcium-mediated
signaling
cytokine induced apoptosis inhibitor 1 CIAPIN1 21.31 4.90 apoptosis, anti-apoptosis
CD24 molecule CD24 24.19 7.00 humoral immune response
dishevelled associated activator of morphogenesis 2 DAAM2 21.71 4.20 actin cytoskeleton organization and biogenesis
attractin-like 1 ATRNL1 21.83 4.80 development
spectrin, beta, non-erythrocytic 1 SPTBN1 21.52 5.30 barbed-end actin filament capping
UNKNOWN
ubiquitously transcribed tetratricopeptide repeat, X
chromosome
UTX 2.13 9.35 ---
zinc finger, BED-type containing 5 ZBED5 21.31 4.30 ---
Nedd4 family interacting protein 2 NDFIP2 21.4 4.60 ---
chromosome 2 open reading frame 25 C2orf25 21.23 4.00 ---
tryptophan rich basic protein WRB 21.47 6.00 ---
PQ loop repeat containing 3 PQLC3 1.77 4.30 ---
CDNA FLJ25488 fis, clone CBR00232 --- 21.34 5.20 ---
family with sequence similarity 79, member B FAM79B 5.94 8.80 ---
X (inactive)-specific transcript XIST 192.07 32.77 ---
CDNA FLJ33569 fis, clone BRAMY2010317 --- 21.47 4.00 ---
hypothetical protein LOC387882 3.04 5.30 ---
chromosome 8 open reading frame 22 C8orf22 2 4.20 ---
chromosome Y open reading frame 15A CYorf15A 22.01 5.10 ---
KIAA1155 protein KIAA1155 1.71 5.10 ---
Prader-Willi syndrome chromosome region 1 PWCR1 21.61 5.00 ---
Heparan-alpha-glucosaminide N-acetyltransferase, similar to
transmembrane protein 76
HGSNAT,
LOC643642
1.53 5.30 ---
hypothetical gene CG018 CG018 1.61 6.60 ---
*Microarray significance .1.2 fold increase or decrease. NLOGP, negative log of the p value, .4.0. N=12 men and 12 women.
doi:10.1371/journal.pone.0006335.t003
Table 3. cont.
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RT-PCR Master Mix Reagent (Roch, Branchburg, New Jersey)
was combined with RNA, target gene primers and probes, and
internal standard gene primers and probes in the same reaction.
Specific primers and probes to each target gene were designed
based on the cDNA sequence in GenBank (http://www.ncbi.nlm.
nih.gov/entrez/query.fcgi) with primer 3 designer (http://frodo.
wi.mit.edu/cgi-bin/primer3/primer3www.cgi.). Their specificity
was monitored using Blast (http://www.ncbi.nlm.nih.gov/
BLAST/). Primer sequences are listed in Table 2.
All probes were dual-labeled with fluorophores, with a
fluorescent reporter dye at the 59 end (FAM, TET, HEX or
TAMRA) and a corresponding quencher dye at its 39 end (3BHQ-
1 or 3BHQ-2). Human b2- microglobulin (b2-M) was used as an
internal standard as there was no significant sex difference in
expression (data not shown). All samples were run in duplicate
simultaneously with RNA- and RT-negative controls. Fluores-
cence emission was detected through a filter corresponding to the
reporter dye at the 59end of each probe, and CT was automatically
calculated and displayed.
Western blot analysis
Thirty mg of tissue was used for protein content analysis.
Muscle tissue was homogenized in a phosphate lysis buffer;
50 mM K2HPO4, 1 mM EDTA, pH 7.4, 0.1 mM DDT, Phos-
STOP (Roach Diagnostics, Mannheim, Germany), Protease
inhibitor cocktail tablets (Roach). Protein concentrations were
calculated by Bradford assay (Biorad) and equal amounts of
protein were boiled in Laemmli buffer, resolved by SDS-PAGE,
transferred to nitrocellulose paper and immunoblotted with
desired antibodies. Primary antibodies; HADHB, ACAA2,
catalase, PPARd, MHC I, MHC II and b-actin were all purchased
from (Abcam, Cambridge, MA). Secondary antibodies conjugated
to horseradish peroxidase (Amersham Bioscience, UK) and
specific antibody binding was detected using the chemilumines-
cence detection reagent ECL+ (Amersham BioScience, UK).
Scanned films were analyzed using ImageJ 1.40 software (Wayne
Rasband National Institute of Health, USA).
Statistical analysis
All statistical analyses, for mRNA content of the genes, was
performed on linear data 2
2CT for evaluation of internal
standards, 2
2DCT for target gene normalized with internal
reference [44]. Data on sex differences about target gene mRNA
content were analyzed using a Student’s t test. All results from
evaluation of target gene are expressed as mean6SEM, using
2
2DCT. Western blot data was normalized by the loading control
(b-actin) and a Student’s t test was preformed to test for a
difference between men and women. Data are presented as
means6SEM. The data regarding muscle fiber composition were
analyzed using a single factor ANOVA and expressed as
mean6SEM. All analyses were done using statistics software
(Statistica version 5.0; Statsoft, Tulsa, OK). Statistical significance
was set at a#0.05.
Results
Sex alters mRNA content in skeletal muscle; microarray
The mRNA abundance in skeletal muscle between men and
women was significantly different for 66 genes (using a stringent
NLOGP$4, fold-change.1.2), after Y-linked genes were re-
moved (Table 3; GEO accession #GSE14901). Of these 66 genes,
49 genes have known functions in metabolism, mitochondrial
function, transport, protein biosynthesis, cell proliferation, signal
transduction pathways, transcription and translation (Table 3).
Conversely, 17 of the genes identified in the current analysis do
Figure 1. Comparison of microarray data to RT-PCR results for 6 genes found to be significantly different between men and
women. Shown as fold change in women versus men. N (microarray)=12 men, 12 women; N (RT-PCR)=12 men, 12 women.
doi:10.1371/journal.pone.0006335.g001
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women had higher content of 25 genes (mean 1.760.4), compared
to men. Subsequently, women have lower content of 24 genes
(mean 22.162.0), compared to men.
iPath
TM (Invitrogen) was used to compared differentially
regulated genes against 225 signaling and metabolic human
biological pathway maps, and these gene were found to be
involved in 39 different signal transduction pathways. Differen-
tially regulated genes were also run against a Connectivity Map to
compare the expression profile to that of known drug treatments,
genes, and diseases. Interestingly, differentially expressed genes
between genders were found to share a similar expression pattern
with the transcript profiling of estradiol (which is estrogenic),
genistein (which could be estrogenic or anti-estrogenic) and
tretinoin (a vitamin A derivative) drug treatments.
Sex alters mRNA content of genes involved metabolism
and mitochondrial biogenesis
Sex altered content of six genes involved in metabolism and
three genes involved in the function of mitochondria and energy
production (Table 3). HADHB (trifunctional protein b), ACAA2,
LPL, UCP-2, catalase, aldehyde dehydrogenase 2 family
(ALDH2), and argininosuccinate synthase 1 (ASS1) all had higher
mRNA content in women compared to men by 1.3- to 2.2-fold.
ALDH1A1 and ATP synthase mitochondrial F1 complex
assembly factor 1 were significantly lower in women compared
to men by 1.9 fold and 1.5-fold respectively (Table 3).
The mRNA content of genes involved in lipid metabolism,
HADHB, ACAA2, and catalase, were confirmed by real time RT-
PCR (Figure 1, 2a, 3a, 4a) using study 2 samples. The mRNA
content of UCP-2, LPL, and ALDH1A1 were also confirmed by
real time RT-PCR (Figure 1, 5), and fold-change of the RT-PCR
results correlated to the fold-change reported by the microarray
(Figure 1).
To determine if sex differences in mRNA content were consistent
with protein content we resolved HADHB, ACAA2, and catalase
on a western blot and found no significant difference in protein
content between men and women (Figure 2c, 3c, 4c;study 2 samples).
Sex difference in muscle fiber composition
Fiber composition data for a subset of study 1 subjects has been
published previously [30]. Fiber composition data for a subset of
study 2 subjects was compared to study 1 and when no differences
were observed the data was combined to increase the n-value and
the data is presented in table 4. Fiber data was consistent with
Figure 2. Sex differences in HADHB. Differences in HADHB muscle
mRNA content between men and women shown by Real time RT-PCR,
adjusted to b2-M mRNA (A). Protein content of HADHB in skeletal
muscle of men and women, adjusted to b-actin (B,C). Lanes 1–4 are
men, lanes 5–8 women, representative of all blots. N=12 men and 12
women. *P,0.05.
doi:10.1371/journal.pone.0006335.g002
Figure 3. Sex differences in ACAA2. Differences in ACAA2 muscle
mRNA content between men and women shown by Real time RT-PCR,
adjusted to b2-M mRNA (A). Protein content of ACAA2 in skeletal
muscle of men and women, adjusted to b-actin (B,C). Lanes 1–4 are
men, lanes 5–8 women, representative of all blots. N=12 men and 12
women. *P,0.05.
doi:10.1371/journal.pone.0006335.g003
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cantly higher area% of Type I fibers (women, 32.961.3; men,
27.361.0; P=0.001) and a significantly lower area% of Type II
fibers (type IIa+type IIx) (women, 67.161.3%; men, 72.761.0%;
P=0.001) than men (Table 4). Women had significantly smaller
mean individual fiber area for type IIa (women, 4777.26347.8 mm
2;
men, 6066.96408.3.8 mm
2; P=0.013), whiletherewas no significant
difference in the type I fiber area or type IIx between women and
men (Table 4).
Sex differences in mRNA content for genes involved in
muscle type determination
The stringent microarray analysis revealed no significant genes
related to muscle type determination. A more biased targeted RT-
PCR approach resulted in the content of MHCI mRNA being
significantly higher in the skeletal muscle of women (2.660.7 fold,
P=0.035) than men (Figure 6a). No significant difference in the
mRNA content of MHCIIa or MHCIIx was found between
women and men (Figure 6c,d). Women had a significantly higher
mRNA content of PPARd than men (2.360.4 fold, P=0.004)
(Figure 7a). There were no significant differences in the mRNA
content of PGC-1a or myostatin in the skeletal muscle of men vs.
women (Figure 8a, 9a). Western blot analysis showed no significant
sex difference in the protein content of MHC I, MHC II, PPARd,
PGC-1a or myostatin (Figure 6b,e, 7c, 8c, 9c). *All data was
acquired from study 2.
Discussion
The purpose of this study was to identify novel differences in
genes related to metabolism, muscle development, and fiber-type
determination and differentiation in mRNA and protein content in
skeletal muscle between men and women at rest using microarray,
Real Time-PCR analysis, and protein analysis. Microarrays are a
Figure 4. Sex differences in catalase. Differences in Catalase mRNA
content between men and women shown by Real time RT-PCR,
adjusted to b2-M mRNA (A). Protein content of catalase in skeletal
muscle of men and women, adjusted to b-actin (B,C). Lanes 1–4 are
men, lanes 5–8 women, representative of all blots. N=12 men and 12
women. *P,0.05.
doi:10.1371/journal.pone.0006335.g004
Figure 5. Skeletal muscle mRNA content of LPL, UCP-2 and
ALDH1A1 in men and women. LPL is higher in women than men
(P=0.009) (A). UCP-2 is higher in women than men (P=0.05) (B).
ALDH1A1 is lower in women than men (P=0.01) (C). b2-M mRNA was
used as an internal standard. N=12 men and 12 women.
doi:10.1371/journal.pone.0006335.g005
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and can help to understand potential pathways involved in regulating
cellular activity in skeletal muscle [33,38,45,46]. The results from
these studies indicate that there are significant differences in mRNA
content between men and women. Roth et al. (2002) and Welle et al.
(2008) have previously shown that there are significant differences in
skeletal muscle mRNA content between men and women, as well as
showing sex differences are significantly greater than age and/or
strength training effects on mRNA content [38,39]. Approximately
30% of the genes we found to have changed due to sex correspond to
the results of Welle and colleagues [39]. Results likely vary between
studies due to differences in age of the subject populations, fitness
variations, low sample numbers, pooled samples on one gene chip
versus individual gene chips per subject, and different gene array
technology [38,39]. The methodology used in this study greatly
strengthens the data regarding sex based differences inskeletal muscle
mRNA for we examined over 23,000 genes with updated annotation,
with 12 subjects per group (N=24 total) hybridized to individual
gene chips for analysis and used stringent statistical analysis with an
NLOGP.4. The criteria for differential expression is stringent
compared to other array studies that generally use an NLOGP.2,
however, necessary for the most accurate unbiased account of gene
content differences. For the microarray experiment we used samples
from study one which included 7 women in the follicular phase and 5
women in the luteal phase, 6 on oral contraceptives and 6 not on oral
contraceptives which gives a good representation of the female
population. Given the high n-value of the analysis and stringent array
analysis criteria we wanted to reduce any variability in gene
expression due to these factors in order to only identify specific and
significant gene differences that can be applied to a larger population.
The goal of the microarray was not to identify genetic differences due
menstrual cycle phase but identify sex related differences between an
average population of men and women. In another manuscript ‘‘in
preparation’’ from study 2 we used a targeted PCR approach to
examine differences in metabolic related genes in men compare to
women in both the follicular and luteal phases of the menstrual cycle
and found that menstrual cycle had little effect on metabolic related
mRNA species, compared to the robust difference that sex has
(Figures S1 and S2). Due to these findings, the little amount of
precious human muscle sample, and the relatively consistent use of
follicular phase women in other gender related studies
[5,11,17,18,19,20,47] we compared the mRNA and protein of
women in the follicular phase only. It is also important to note that
Devries et al (2006) report no physiological difference in exercise
performance due to menstrual cycle phase including average RER,
glycogen utilization, glucose rate of appearance, rate of disappear-
ance, and metabolic clearance rate averaged over the exercise period
[41].
The first focus was on the mRNA content of genes involved in
intermediary substrate metabolism due to the known fact that
women oxidize more fat during endurance exercise as compared
with men [5,6,7,8,10,11,48]. Array results identified six genes
related to metabolism that were differentially regulated between
men and women. We chose to confirm the mRNA content of five
of these genes by RT-PCR. Results identified a novel sex-based
difference in the mRNA content of ACAA2 and HADHB (TFP-b).
Also, the mRNA content for catalase, lipoprotein lipase, and
uncoupling protein-2 were higher in women compared with men.
Lastly, ALDH1A1 mRNA content was lower in women compared
with men. There was also sex based differences in the mRNA
content of genes involved in protein biosynthesis, cell proliferation,
signal transduction, transcription, and translation with a particular
interest in those genes which are directly involved in muscle
function and/or structure.
HADHB (TFPb) is a multi-enzyme complex found in the
mitochondria that is involved in the b-oxidation of fatty acids [49].
Specifically, the TFP enzyme catalyzes the last three steps of long
chain fatty acid b-oxidation for long-chain specific acyl-CoA
moieties. We are the first to measure and report a sex difference in
the mRNA content for this gene. An enhanced b-oxidation
capacity distal to transport of FFA into the mitochondria may
allow for maintenance of b-oxidation when the cell is under
metabolic stress. For example, male transgenic peripheral
peroxisome activating receptor knockout (PPARa
2/2) animal
develop severe hypoglycemia when an inhibitor of CPT activity
(etomoxir) was given, yet the majority of female mice survived
[50]. Furthermore, CPTII deficiency is an autosomal recessive
condition and yet many more cases have been documented in men
as compared with women, possible due to enhanced b-oxidation
capacity in women. Others have reported that the short-chain
specific isoform of HAD (SCHAD) has higher mRNA and protein
abundance in women compared with men [2,51].
These results also indicate a significant sex based difference in
the mRNA content of ACAA2 (acetyl-Coenzyme A acyltransferase
2). ACAA2 is one of two isoforms of ACAA, which is an
intracellular enzyme that biosynthesizes cholesteryl esters. Specif-
ically, ACAA is involved in storing cholesteryl esters as lipid
droplets, in absorbing dietary cholesterol, and in providing
cholesteryl esters as part of the core lipid for lipoprotein synthesis
and assembly [52,53,54]. Although ACAA appears to be present
in many cell types such as hepatocytes, adrenal cells, skin cells,
intestinal enterocytes, neurons, and macrophages it has not been
well characterized in skeletal muscle [55,56]. In the aforemen-
tioned cell types it has been shown that the ACAA1 isoform is the
predominant enzyme compared to ACAA2 [55]. Our gene array
results suggest that men and women have no significant difference
in the expression of ACAA1 but women have an increased
expression of ACAA2 compared to men. Therefore, the total
ACAA expression should be significantly higher in women than
men, which may explain why lipids are more readily available for
substrate utilization during endurance exercise in women. Future
studies are needed to determine the expression profile of ACAA1
and ACAA2 in human skeletal muscle as well as the importance of
ACAA2 over-expression in women compared to men.
Catalase is one of the three primary antioxidant enzymes. RT-
PCR confirmed that mRNA content for catalase is significantly
higher in women compared to men. Interestingly, Fano et al
(2001) have shown that the enzyme activity of catalase, in the vastus
lateralis, is significantly higher in women than men [57]. Sex
Table 4. Fiber type composition in the vastus lateralis muscle
of women and men.
Men (N=10) Women (N=16)
Fiber type composition (area%)
Type I 27.361.0 32.961.3 *
Type IIa+IIx 72.761.0 67.161.3 *
Mean area per fiber (mm
2)
Type I 4218.66225.0 4691.76477.9
Type IIa 6066.96408.3 4777.26347.8 *
Type IIx 5208.76220.3 4677.76389.8
Sex differences in fiber type composition between men and women. Due to
experimental difficulties data is a combined subset of samples from both study
#1 and study#2. Means6SEM *P,0.05.
doi:10.1371/journal.pone.0006335.t004
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including manganese-superoxide dismutase [58], suggesting that
women are better protected against reactive oxygen species (ROS)
as compared with men. We also demonstrated that mRNA
content for UCP2 was higher in women compared to men. UCP’s
can affect energy metabolism efficiency by uncoupling ATP
production from mitochondrial respiration. UCP2 is involved in
the regulation of energy metabolism and might play a role in
obesity [59,60,61]. UCP2 has also been suggested to affect the
production of reactive oxygen species (ROS) [62,63,64], and
regulate the [ATP]/[ADP] ratio [64,65,66]. Although we are the
first to show a sex specific difference in mRNA content in the vastus
lateralis, this may help to explains why young women are protected
against ROS (reviewed in [67]). Furthermore, if UCP2 does play a
role in obesity the higher expression in women might help to
regulate lipid oxidation.
ALDH1A1 is an isoform of the aldehyde dehydrogenase
superfamily primarily responsible for the oxidation of endogenous
and exogenous aliphatic and aromatic aldehydes including
acetaldehyde, benzaldehyde, 4-hydroxynonenal, malondialde-
hyde, and retinaldehyde [68,69,70]. Recently ALDH1A1 was
also shown to convert 3-deoxyglucosone into 2-keto-3-deoxyglu-
conate [71]. In this study we found that the mRNA content was
lower in women compared with men, suggesting that men might
be able to metabolize aldehydes (i.e. alcohol) more efficiently than
women. ALDH1A1 has not been well characterized in humans, let
alone skeletal muscle, but in the mouse liver and human colon
there appears to be no sex differences in activity [72,73]. Further
Figure 6. Sex differences in MHC isoforms. Differences in MHC I muscle mRNA content between men and women shown by Real time RT-PCR,
adjusted to 28 S rRNA (A). Protein content of MHCI in skeletal muscle of men and women, adjusted to b-actin (B). MHC IIa (C) and MHC IIx (D) muscle
mRNA content in men and women shown by Real time RT-PCR, adjusted to 28 S rRNA. Protein content of MHC II in skeletal muscle of men and
women (E). Lanes 1–4 are men, lanes 5–8 women, representative of all blots. N=12 men and 12 women. *P,0.05.
doi:10.1371/journal.pone.0006335.g006
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in skeletal muscle need to be conducted.
These results also showed sex specific differences in genes
involved in cell transport, protein biosynthesis, cell proliferation,
signal transduction pathways, transcription and translation. Of
interest, women had a 2.2-fold reduction in the solute carrier
family 1, member 4 that is involved in glutamate/neutral amino
acid transport which could be important in metabolism. Women
had a 1.7-fold increase in mRNA content of angiopoietin 1, a
factor involved in increasing vascularization to a specific tissue, in
this case, muscle; however, there does not seem to be a significant
difference in capillarization of the tibialis anterior or vastus lateralis
muscle of women compared to men [74,75]. Women also had a
1.7- and 1.5-fold reduction in Dishevelled associated activator of
morphogenesis 2, and spectrin- beta- non-erythrocytic 1 which are
involved in actin cytoskeleton organization and biogenesis, and
barbed-end actin filament capping, respectively. Both are
important in muscle cell shape and function. There was an
interesting trend in the expression of signal transduction genes and
transcription factor genes. Women had a significant up-regulation
of the majority of signal transduction related genes and a
significant down-regulation of the majority of transcription factor
genes. Despite these trends, there was no evidence that one signal
transduction pathway was favored over another as the identified
genes spanned multiple pathways including the MAPK pathway,
frizzled signaling pathway, G-protein coupled receptor protein
signaling pathway, and insulin receptor signaling pathway.
It is important to note that gene array analysis works on the
assumption that basal mRNA equates into changes at the protein
level and thus activity level. However, recent studies have been
demonstrating that is not always the case. For example Kiens et al.
(2004) demonstrated that women have a significantly higher LPL
mRNA content; however there was no observed differences in
LPL activity between men and women [47]. Similarly, Roepstorff
et al. demonstrated that although mRNA and protein expression
of hormone sensitive lipase (HSL) was higher in women,
phosphorylation activation was significantly higher in men [11].
Another study in skeletal muscle biology also found discrepancies
in the correlation between mRNA and protein content of a
number of genes related to fatty acid oxidation [76]. Part of the
discrepancy between mRNA abundance and protein and enzyme
Figure 7. Sex differences in PPARd. Differences in PPARd muscle
mRNA content between men and women shown by Real time RT-PCR,
adjusted to b2-M mRNA (A). Protein content of PPARd in skeletal muscle
of men and women, adjusted to b-actin (B,C). Lanes 1–4 are men, lanes
5–8 women, representative of all blots. N=12 men and 12 women.
*P,0.05.
doi:10.1371/journal.pone.0006335.g007
Figure 8. Sex differences in PGC1a. Differences in PGC1a muscle
mRNA content between men and women shown by Real time RT-PCR,
adjusted to b2-M mRNA (A). Protein content of PGC1a in skeletal
muscle of men and women, adjusted to b-actin (B,C). Lanes 1–4 are
men, lanes 5–8 women, representative of all blots. N=12 men and 12
women. *P,0.05.
doi:10.1371/journal.pone.0006335.g008
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assaystechnique, and/or that the transcriptome abundance
regulates multiple interacting and synergistic pathways that
combine to influence flux through metabolic pathways at the
protein level that is below the detectable threshold for statistical
changes in a single given protein to be manifested. In order to fully
understand cellular differences between men and women it is
important to understand pre-translational (mRNA abundance),
translational (protein) and post-translational (phosphorylation)
levels of control.
It has recently been hypothesized that some of the sex
differences in exercise substrate selection may be due to fiber-
type compositional differences [32]. Subject fiber type character-
istics were the same in this study as previously reported
[4,5,26,27,30,32]; specifically, the proportionate area (area%) of
type I fibers was higher, while that of type II fibers was lower, in
women compared with men. Previous findings of a sex difference
in type I fiber proportion [25,28,29,32] and a larger type I fiber
area [4,5,27,30], in women as compared with men were not
confirmed. Nevertheless, it is the proportion of the total muscle
area represented by a given fiber type (area X proportion=area%)
that should determine the overall abundance of a given transcript
or protein in a homogenate of skeletal muscle. Examination of
mRNA expression of myosin heavy chain genes, which are
specifically expressed in their corresponding muscle fiber types
[77], are good markers of the terminal differentiation of muscle
fibers. In this study, we found a significantly higher mRNA
content of MHCI and a similar mRNA content of MHCIIa and
MHCIIx in the skeletal muscles of women compared with men.
The difference in MHCI mRNA did not translate into differences
in MHCI protein expression, consistent with previous findings
[30].
Similarly, we found sex differences in the mRNA content, but
not the protein content, of PPARd; which plays a role in the
conversion of muscle fiber type II into type I and maintenance of
the number of type I fibers [78], and increases the capacity for
oxidative metabolism of muscle fibers through hyperplasia of type
I fibers [79,80] in transgenic mice.
Strong evidence in transgenic mice [81], and controversial
evidence in humans [82,83,84], suggests that PGC-1a is important
in the determination of muscle fiber type and induces a fiber type
transformation from type II into type I muscle fibers. We did not
find an influence of sex on the mRNA or protein content of PGC-
1a in skeletal muscle in spite of the fact that women had a higher%
area of type I fibers. We also found that there was no sex difference
in the mRNA content of myostatin, a negative regulator of skeletal
muscle growth [85,86,87].
At rest, there are no significant differences in protein content of
the select genes examined, which are involved in metabolism or
fiber type. Consistently, there are no observed sex differences in
substrate utilization at rest [7,8,88,89,90]. However, mRNA
content suggest that men and women are ‘‘primed’’ differently
for specific cellular events, and future studies are need to
determine if exercise induces changes at the translational and
post-translational levels.
Overall, these results identified sex-based differences in mRNA
content of metabolic related genes that might lead the way towards
an understanding of the sex-based differences in metabolic fuel
selection during endurance exercise. Furthermore, this study
emphasizes the importance of the influence of sex based
differences in gene expression. At the mRNA level there are no
inconsistencies in our data or in the literature, which supports that
women have higher mRNA abundance for genes involved in fat
metabolism as compared with men. Furthermore, men and women
demonstrate varied regulation of genes involved in mitochondrial
function, transport, protein biosynthesis, cell proliferation, signal
transduction pathways, transcription and translation, even at rest.
Supporting Information
Table S1 Affymetrix gene array analysis comparing resting
human skeletal muscle of women with men. Original Affymetrix
data. LogFC; Log fold-change, NLogP;negative log of the p value
(.4.0), F; Woman M; Man.
Found at: doi:10.1371/journal.pone.0006335.s001 (0.04 MB
XLS)
Figure S1 Menstrual cycle differences in resting mRNA content
of genes related to substrate metabolism. Genes are expressed as
mean fold difference follicular/luteal6SEM. b2-M mRNA was
used as an internal standard. N=12 men and 12 women.
*P,0.05.
Found at: doi:10.1371/journal.pone.0006335.s002 (1.37 MB TIF)
Figure S2 Sex differences in resting mRNA content of genes
related to substrate metabolism. Genes are expressed as mean fold
Figure 9. Sex differences in myostatin. Differences in myostatin
muscle mRNA content between men and women shown by Real time
RT-PCR, adjusted to b2-M mRNA (A). Protein content of myostatin in
skeletal muscle of men and women, adjusted to b-actin (B,C). Lanes 1–4
are men, lanes 5–8 women, representative of all blots. N=12 men and
12 women.
doi:10.1371/journal.pone.0006335.g009
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internal standard. N=12 men and 12 women. *P,0.05.
Found at: doi:10.1371/journal.pone.0006335.s003 (1.83 MB TIF)
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